3 results
The main objective of Study M15-722 is to characterize the efficacy, safety, and tolerability of ravagalimab (ABBV-323) as induction treatment in subjects with moderately to severely active UC.
The aim of the proposed randomized controlled trial (RCT) is to determine the effectiveness, and related healthcare costs of a mHealth-based targeted clinical monitoring pathway in GUCH patients. The primary research question is to assess the effect…
The general objective is to study gender differences in the magnitude of CRT response in a HF population with an equal distribution of women and man in order to examine the interrelationship among CRT effect, gender and baseline clinical factors (e.…